surges

Corporate Treasuries’ AI Investment Surges Despite Low ROI

Though ROI is relatively low for finance organizations, many have cracked the code for higher returns.

A recent Bain & Company survey reveals that less than half (48%) of senior financial executives have seen improvements in speed and cycle time since investing in artificial intelligence (AI) within their treasury organizations, and around a third (34%) have seen headcount efficiencies and cost reductions. 

Over the past 12 months, most enterprises have discussed AI use cases in corporate treasuries for accounts receivable, treasury, and accounts payable, and have experimented extensively with AI. “They have approached it more from the concept ‘Here’s an intelligence, let’s see how we can incorporate it into our business,’” said Rami Chahine, Chief Product and Technology Officer, at treasury-automation vendor Serrala.

“This is making the office of CFO more of an AI lab than anything,” he continued. “We are not seeing real adoption of active use cases deployed within our customer base. We see a lot of our enterprise customers bringing technology or spending, in some cases,  a lot of money on technology, but haven’t really turned on agentic AI to truly realize their return-on-investment in terms of speed of delivery and the speed of work.”

According to the Bain study authors,  that is a common situation within finance departments. Of the survey respondents, roughly 12% of finance organizations have deployed machine learning into financial planning and analysis (FP&A) forecasting in production.

“Yet in many cases, the underlying process hasn’t changed,” wrote the authors. “Finance teams run AI-generated forecasts alongside existing bottom-up planning cycles: two processes running in parallel, neither fully trusted.”

As a result, these finance organizations do not realize the expected benefits of faster cycle times, fewer people-hours, or greater accuracy.

AI Can’t Fix GIGO

According to the authors, it isn’t a technology problem. “It’s what happens when AI is layered on top of existing ways of working rather than providing the impetus to change them. If this workflow debt isn’t addressed, AI and automation can multiply complexity instead of productivity,” they wrote.

Other issues that act as headwinds to AI investment include concerns about trust, data sovereignty, and the ability of firms to audit AI’s data usage.

AIs are built to learn, but CFOs are concerned that only their instance of the AI is using their proprietary data to answer only their questions, rather than teaching other AI instances to answer someone else’s questions, said Chahine.

“Everyone believes in the capability,” he said. “Everyone understands the power of agentic AI and its ability to take over some of these manual tasks in the process of financial automation and treasury. But the biggest concern that will make a true impact on adoption is whether we can trust it.”

Despite these issues, CFOs remain bullish about AI investment in their organizations.

More than half (56%) of the surveyed CFOs are increasing AI investment by more than 15% this year. That figure rises to 83% when the window is extended to two years,  with 42% of respondents expecting to increase AI spending to above 30% over the same period.

Source link

Brits abroad issued health warning as illness surges across Europe and beyond

Health experts are urging Brits to ensure they are “up-to-date” with their vaccines

Brits planning a summer getaway have been urged to ensure they are “up-to-date” with their vaccinations. The warning follows an “increase” in measles cases globally, including across parts of Europe and Asia.

Measles is a highly infectious viral infection that triggers cold-like symptoms, red eyes, and a characteristic blotchy rash. In severe instances, it can result in serious complications such as meningitis and seizures, and can be fatal.

In guidance published on the Travel Health Pro website, experts highlighted that the disease has risen in numerous countries. They said: “The summer holidays provide opportunity to explore different countries, head off for a city break, have a beach holiday or take the children to visit friends and family overseas.

“Good preparation and planning ahead helps ensure a safe and enjoyable trip. Travellers should be up to date with routine vaccination courses and boosters as recommended in the UK.

“These vaccinations include, for example measles-mumps-rubella (MMR). Measles is a risk in many countries, and there has been an increase in measles cases and outbreaks reported worldwide, including in parts of Africa, Asia, Europe, and the Americas, including Canada and the United States.” Data from the European Centre for Disease Prevention and Control revealed that a total of 3,607 measles cases were reported by 30 EU/EEA member states in the year following 1 April 2025.

Breaking down the figures further, it stated: “Of 3,029 individuals (84.0 per cent of all cases) with a known age and vaccination status, 2 369 (78.2 per cent) were unvaccinated, 320 (10.6 per cent) were vaccinated with one dose of a measles-containing vaccine, 301 (9.9 per cent) were vaccinated with two or more doses, and 32 (1.1 per cent) were vaccinated with an unknown number of doses.

“During the 12-month period, five deaths (case fatality rate (CFR): 0.139 per cent) attributable to measles were reported to ECDC by France (three), Netherlands (one) and Romania (one).”

Meanwhile, a report by the World Health Organisation (WHO) and United Nations Children’s Fund (UNICEF) discovered that measles cases in Europe reached their highest level in 2024 since 1997. A total of 127,350 measles cases were recorded in the European Region in 2024, double the figure reported for 2023 and the highest number since 1997.

Children under five made up more than 40 per cent of reported cases in the Region – covering 53 countries across Europe and Central Asia. Over half of the reported cases necessitated hospitalisation. A total of 38 deaths have been documented, according to preliminary data received as of 6 March 2025. The resurgence has been linked to falling vaccination rates. Dr Hans P Kluge, WHO regional director for Europe, warned: “Measles is back, and it’s a wake-up call. Without high vaccination rates, there is no health security. As we shape our new regional health strategy for Europe and Central Asia, we cannot afford to lose ground.

“Every country must step up efforts to reach under-vaccinated communities. The measles virus never rests-and neither can we.”

Measles cases are also on the rise across the UK. Figures from the UK Health Security Agency (UKHSA) revealed that in 2024, there were 2,911 laboratory-confirmed measles cases in England – the highest annual total recorded since 2012. In 2025, there were a total of 959 laboratory-confirmed measles cases. Data for 2023 to 2025 and historical data are available.

Between 1 January 2026 and 11 May 2026, there have been 542 laboratory-confirmed measles cases reported in England, an increase of 65 cases since the last report on 27 April 2026.

Symptoms

The virus transmits very quickly. Initial symptoms typically resemble those of a common cold, with a distinctive rash emerging several days afterwards.

The first symptoms of measles can include:

  • A high temperature
  • A runny or blocked nose
  • Sneezing
  • A cough
  • Red, sore, watery eyes

The rash initially appears on the face and behind the ears, subsequently spreading across the entire body. Occasionally, the spots associated with the measles rash become raised and merge, creating blotchy patches. These are typically not itchy.

The NHS cautions that measles can trigger severe complications should it migrate to other bodily areas, particularly the lungs or brain. Potential consequences include pneumonia, meningitis, loss of vision, and convulsions. In the most serious instances, the disease can be life-threatening.

How to prevent the spread

Measles is spread when an infected person breathes, coughs or sneezes. You’re infectious from when you first have symptoms (around four days before the rash appears) until four days after you get the rash.

The NHS advises that to curb the transmission of the infection, individuals must remain absent from educational institutions or workplaces for a minimum of four days following the emergence of the rash. According to its website, the guidance states: “Stay off nursery, school or work for at least four days from when the rash first appears. Also try to avoid close contact with babies and anyone who is pregnant or has a weakened immune system.”

However, the initial step if you or your child develops measles is to arrange an urgent consultation with your GP. The NHS advises: “Measles can spread to others easily. Call your GP surgery before you go in.

“They may suggest talking over the phone or arrange for you to come to a part of the surgery where you’re separated from others. You can also call 111 or get help from 111 online.”

After seeing a GP, there are things you can do to help ease the symptoms and reduce the risk of spreading the infection. It can help to:

  • Rest and drink plenty of fluids, such as water, to avoid dehydration
  • Give your child paracetamol for children or ibuprofen for children if they’re distressed or uncomfortable – check the packaging or leaflet to make sure the medicine is suitable for your child, or speak to a pharmacist or GP if you’re not sure
  • Adults can take paracetamol or ibuprofen for a high temperature
  • Use cotton wool soaked in water that has been boiled and allowed to cool to gently remove any crusts from your or your child’s eyes
  • The NHS also recommends you:
  • Open windows and doors to help reduce the risk of measles spreading – only open the top window or use safety catches if you have young children
  • Wash your hands often with soap and warm water
  • Use tissues when you cough or sneeze and throw them in the bin immediately after using them
  • Do not share cutlery, cups, towels, clothes, or bedding

Vaccination

Having the MMRV or MMR vaccine is the “best way” to prevent measles. The NHS says: “Both vaccines also protect you from mumps and rubella, and the MMRV vaccine also protects you from chickenpox.

“The MMRV vaccine is offered to all young children in the UK. The MMR vaccine is recommended for adults and older children if they were not vaccinated when they were younger.”

Ask at your GP surgery if you’re not sure you or your child has had either of these vaccines. Your GP can vaccinate you for free on the NHS.

Source link

Oil temporarily surges above $126 per barrel as Iran war seemingly intensifies

Published on Updated

Brent crude, the international standard for oil prices, jumped by over 7% during early trading on Thursday, touching $126 per barrel, the highest intraday level since 2022 when Russia initiated the full-scale invasion of Ukraine.


ADVERTISEMENT


ADVERTISEMENT

The US benchmark crude, WTI, also rose more than 3% and hit over $110 per barrel.

At the time of writing, prices have corrected slightly with the front month contract for Brent trading at around $122 per barrel and WTI at roughly $108.5.

Prices are now the highest they have been since the start of the Iran war.

The surge in oil prices is a direct consequence of stalled negotiations over the reopening of the Strait of Hormuz, the absence of a clear path toward ending the war and a seemingly increased chance of US-Israeli military action returning.

US President Donald Trump is set to meet with the head of the US Central Command, Admiral Brad Cooper, on Thursday and receive a briefing on new military options for action in Iran, according to Axios which cites two unnamed people.

The meeting signals the potential for fresh escalation in the Middle East as the resumption of combat operations is reportedly “seriously under consideration” and oil markets have reacted swiftly to the news.

A ceasefire has held since early April but recent negotiating efforts have fallen flat with the two sides refusing to meet. Meanwhile, the US and Iran both maintain their blockade of the vital Strait of Hormuz.

US Central Command has also reportedly asked for hypersonic missiles to be sent to the Middle East, which would mark the first time the US army has deployed that type of weapon.

The persistent blockade of ports and the threat of expanded combat have fundamentally reshaped market expectations.

A shifting landscape for OPEC and global supply

The spike in prices is occurring against a backdrop of significant structural change within the global oil hierarchy.

Earlier this week, the United Arab Emirates officially withdrew from the Organisation of the Petroleum Exporting Countries (OPEC) and its wider alliance (OPEC+), a move the nation claimed was necessary to prioritise its own national interests.

Under normal market conditions, the exit of a major producer from the cartel might be expected to signal a potential increase in supply or a decrease in price stability.

However, the sheer scale of the Iran war has rendered the UAE’s departure secondary in the minds of traders.

Despite the UAE’s exit, which was expected to potentially weaken OPEC’s grip on production quotas, prices have continued their upward trajectory.

This suggests that the “war premium” currently dominates all other market fundamentals.

Investors are currently less concerned with the internal politics of oil-producing nations and more focused on the immediate physical absence of Iranian crude, suspended shipping routes through the Strait of Hormuz and the threat to regional infrastructure.

However, the transition of the UAE to an independent actor still highlights a growing fragmentation in global energy governance at a time when the world’s energy security is at its most vulnerable.

Source link